JPRN-UMIN000014963已完成4 期
Comparison of efficacy of ipraglifrozine and high-dose metformin in patients with type 2 diabetes - COLOR stduy
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. treated by insulin injection 2. unstable diabetic retinopathy 3. advanced liver, renal or cardiac disease(s) 4. allergy to metformine or ipraglyfrozine 5. (possible) pregnant or breast-feeding women 6. those with severe ketosis or diabetic (pre)coma 7. those with severe infection or trauma, or before/after sugery 8. those who are inappropriated for the present study
研究者
相似试验
已完成
不适用
Efficacy and safety of Ipragliflozin in patients with type 2 diabetes who have inadequate glycemic control.Type 2 diabetesJPRN-UMIN000014306akakinen clinic100
已完成
不适用
Randomized comparative study of ipragliflozin combination therapy and sitagliptin combination therapy in patients with type 2 diabetes administrating metformiType 2 diabetesJPRN-UMIN000018364iigata University Fuculty of Medicine166
尚未招募
不适用
Efficacy and Safety of Ipragliflozin, a selective SGLT2 inhibitor, in type 2 diabetes patients with insulin therapytype 2 diabetesJPRN-UMIN000014968Tokyo Medical University Hospital Division of Diabetes,Metabolism and Endocrinology50
已完成
4 期
Comparison of efficacy of ipraglifrozine and high-dose metformin in patients with type 2 diabetesD003924Diabetes Mellitus, Type 2JPRN-jRCTs011180024Watanabe Taku140
招募中
3 期
Comparing the effectiveness of Empagliflozin with Metformin in controlling Diabetes Mellitus in patients with post-organ transplant diabetesIRCT20230315057726N1Islamic Azad University40